New heart monitor to help manage PVCs
Part of Heart & circulation clinical trials.
This trial tests if a small heart monitor (ILR) made by Medtronic can help doctors better manage premature heartbeats (PVCs). If you already have this monitor, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18.
- You already have a Medtronic LINQ II heart monitor (ILR) implanted.
- You are willing and able to agree to be in the study.
- You have not had a heart attack or heart stoppage before.
- You do not have a defibrillator or a severely blocked heart artery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults with frequent extra heartbeats (PVCs) to better understand how myocarditis may be causing them. If you qualify, your care team may review your heart rhythm data and other heart imaging/testing to see how this condition relates to your symptoms and risk.
This trial studies people who had a heart valve procedure called TAVI and later had a heart rhythm problem. You will get a tiny heart monitor placed under your skin to track your heart rhythm over time and help doctors understand how common these problems are.
This trial tests whether treating frequent PVCs (extra heartbeats) can help protect the heart’s pumping strength in people who currently feel fine. It specifically looks at patients with a high PVC burden but normal heart function, using a preventative approach.
This study tests whether a home telemonitoring system can help spot heart rhythm problems early in people with heart failure. It may help doctors detect rhythm issues sooner so treatment can be adjusted faster.
This study checks how often abnormal heart rhythms happen when you start a BTK inhibitor (used for certain blood cancers). It uses a small implanted heart monitor to record your rhythm continuously before and after starting the medication, so doctors can detect and manage problems early.
This study tests a home-monitoring device that tracks irregular heartbeats in patients with a pacemaker. The device sends information to doctors so they can catch and treat problems early.
Hear when a new Myocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.